CIK 0001737927 · Medicinal Chemicals & Botanical Products (SIC 2833) · Nasdaq · incorporated in Z4 · fiscal year ends 03/31
| FY2026 | FY2025 | |
|---|---|---|
| Revenue (CAD) | 284603000 | 333253000 |
| Net income (CAD) | -262908000 | -3278158000 |
| Diluted EPS (CAD/shares) | -0.88 | -70.69 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | DEFA14A | DEFA14A | |
| 2026-10-16 | 8-K | FORM 8-K items 3.01 | 2026-10-14 |
| 2026-10-06 | DEFA14A | DEFA14A | |
| 2026-09-30 | 4 | OWNERSHIP DOCUMENT | 2026-09-28 |
| 2026-09-30 | 4 | OWNERSHIP DOCUMENT | 2026-09-28 |
| 2026-09-30 | 4 | OWNERSHIP DOCUMENT | 2026-09-28 |
| 2026-09-30 | 4 | OWNERSHIP DOCUMENT | 2026-09-28 |
| 2026-09-25 | DEFA14A | DEFA14A | |
| 2026-09-17 | 4 | OWNERSHIP DOCUMENT | 2026-09-17 |
| 2026-09-15 | DEFA14A | DEFA14A | |
| 2026-08-25 | 4 | OWNERSHIP DOCUMENT | 2026-08-24 |
| 2026-08-25 | 4 | OWNERSHIP DOCUMENT | 2026-08-24 |
| 2026-08-17 | DEFA14A | DEFA14A | |
| 2026-08-14 | DEFA14A | DEFA14A | |
| 2026-08-07 | DEFA14A | DEFA14A | |
| 2026-08-07 | ARS | ARS | 2026-03-31 |
| 2026-08-07 | DEF 14A | FORM-DEF 14A | 2026-09-25 |
| 2026-08-07 | 8-K | FORM 8-K items 4.01,9.01 | 2026-08-07 |
| 2026-08-07 | 8-K | 8-K items 2.02,9.01 | 2026-08-07 |
| 2026-08-07 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-17 | PRE 14A | FORM PRE 14A | 2026-09-25 |
| 2026-06-29 | 4 | OWNERSHIP DOCUMENT | 2026-06-26 |
| 2026-06-29 | 4 | OWNERSHIP DOCUMENT | 2026-06-26 |
| 2026-06-29 | 4 | OWNERSHIP DOCUMENT | 2026-06-26 |
| 2026-06-29 | 4 | OWNERSHIP DOCUMENT | 2026-06-26 |
Forms on file (last 1,000): 6-K 189, 4 164, 8-K 118, DEFA14A 55, 424B3 44, 3 23, 10-Q 19, UPLOAD 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CGC (0.002 USD), /gw/filings/filings?ticker=CGC&form=8-K, /gw/filings/facts?ticker=CGC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange